Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Composition : Olmesartan medoxomil 20 mg + amlodipine 5 mg + hydrochlorothiazide 12.5 mg tablet
Dosage Form : Tablet
Packaging Type : Alu Alu
Packaging : 10*10
Price : ₹1/-
Olmetyle AMH 20 Tablet is a triple-combination antihypertensive formulation consisting of Olmesartan Medoxomil (20 mg), Amlodipine (5 mg), and Hydrochlorothiazide (12.5 mg). Olmesartan is an angiotensin II receptor blocker (ARB) that inhibits vasoconstriction and aldosterone secretion. Amlodipine is a calcium channel blocker that relaxes vascular smooth muscles to enhance blood flow. Hydrochlorothiazide, a thiazide diuretic, reduces plasma volume by promoting excretion of sodium and water. This three-pronged approach results in potent and sustained control of high blood pressure, improving cardiovascular outcomes and reducing the risk of stroke, heart failure, and renal complications.
Olmeslide AH 20 Tablet is generally well tolerated. Some patients may experience dizziness, headache, swelling of ankles (due to Amlodipine), or increased urination (due to Hydrochlorothiazide). Electrolyte imbalance, muscle cramps, or fatigue may rarely occur. Serious adverse effects are uncommon but require immediate medical attention.
Indicated for the management of essential hypertension, especially in patients who require a combination of three antihypertensive agents for effective blood pressure control. It is often prescribed when monotherapy or dual therapy fails to achieve target blood pressure.
Use under medical supervision only. Not recommended during pregnancy, especially in the second and third trimesters, due to the risk of fetal toxicity. Caution should be exercised in patients with renal or hepatic impairment. Regular monitoring of blood pressure, renal function, and electrolyte levels is advised.
Store at a temperature below 30°C, away from moisture and direct sunlight. Keep out of reach of children.
Composition : Olmesartan medoxomil 40 mg + amlodipine 5 mg + hydrochlorothiazide 12.5 mg tablet
Composition : Olmesartan Medoxomil 20 mg tablet
Composition : Olmesartan Medoxomil (40mg) tablet
Composition : Olmesartan 20 mg + Hydrochlorothiazide 12.50 mg tablet
Composition : Olmesartan 40 mg + hydrochlorothiazide 12.50 mg tablet
Composition : Olmesartan medoxomil 20 mg + amlodipine 5 mg tablet
Composition : Olmesartan medoxomil 40 mg + amlodipine 5 mg tablet
Composition : Olmesartan medoxomil 20 mg + chlorthalidone 12.5 mg tablet
Composition : Nitroglycerine 2.6 mg Tablet
Composition : Nitroglycerine 6.4 mg Tablet
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Strategic Advisory
Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.
View Professional Profile
Start Your Journey
Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!
Quick Navigation